Patient Power®
Get Email Alerts!
Health Topics
Prostate Cancer Health Center
Health Center Home Audio Programs Videos Advanced Prostate Cancer
Search by Keyword:
Search by Health Topic:
View all Health Topics >
5/29/12

Active Immunotherapy: Could It Benefit Men at An Earlier Stage of Prostate Cancer?

In this video, Dr. Paul Schellhammer discusses recent research that suggests that active immunotherapy could be used to treat earlier stages of prostate cancer and shares his perspective about what he believes this means for men with less advanced disease. Dr. Schellhammer also explains how this research changes the landscape of treatment and what he feels are developing areas of hope for men with men with advanced and/or metastatic disease.

Health Topics: Prostate Cancer

Get Email Updates:

Get updated automatically when new content about Prostate Cancer has been posted.
Privacy Policy
Prostate Cancer

Experts & Guests

Paul F. Schellhammer, MD Paul F. Schellhammer, MD
Program Director, Virginia Prostate Center, Eastern Virginia Medical School
Dr. Paul F. Schellhammer is the program director of the Virginia Prostate Center and professor of urology at Eastern Virginia Medical School. Dr. Schellhammer earned his undergraduate degree at the University of Notre Dame in 1962 and graduated from Cornell Medical College in 1966. He completed a surgical internship and a surgical residency at University Hospitals of Cleveland in Ohio,... more >

Transcript

  1. Active Immunotherapy: Could It Benefit Men at An Earlier Stage of Prostate Cancer?

Related Videos

Dr. David Quinn explains study results that suggest that African American men with metastatic castrate resistant prostate cancer (MCRPC) may receive a greater survival benefit from treatment with active cellular immunotherapy. Dr. Quinn also discusses research and therapies in development that are showing promise for treating advanced prostate cancer.

Watch Now
In this video, Dr. Chadi Nabhan explores the phase III results of the IMPACT study for men living with advanced prostate cancer...

Watch Now
Dr. Leonard Gomella responds to a recent US government panel recommendation suggesting discontinuation of the PSA test to detect prostate cancer, a recommendation which he believes could be “devastating."

Watch Now